Visitor publication

Good news! Our hospital won the honor of advanced collective and individual in neonatal disease screening

Posting time:2023-01-31 08:26:04

Good news! Our hospital won the honor of advanced collective and individual in neonatal disease screening

On July 29, 2022, the 2021 Zhejiang Newborn Disease Screening Work Summary and Advanced Commendation Conference was successfully held in Hangzhou. Hangzhou Neonatal Disease Screening Management Center and Hangzhou Urban Neonatal Disease Screening Management Center won the Advanced Group and Quality Award for Neonatal Genetic Metabolic Disease Screening; Wu Ting of Hangzhou Maternal and Child Health Hospital was awarded the title of Excellent Quality Controller. Hangzhou Maternal and Child Health Hospital won the advanced group for newborn congenital heart disease screening. Since 1999, our hospital has been responsible for the city's newborn disease screening management project, responsible for the management of newborn genetic metabolic disease screening and newborn hearing screening in the whole region; in 2019, it has been responsible for the management of newborn congenital heart disease screening check. After screening, diagnosed in the past 3 years: congenital hypothyroidism (CH) 430 people with glucose-6-phosphate dehydrogenase deficiency (G6PD) 774 people with congenital adrenal hyperplasia (CAH) 10 people with phenylketonuria (PKU) 9 people with other genetic metabolic diseases 74 people with congenital hearing abnormalities 748 people After a series of interventions, the quality of life of these children has been greatly improved. In the future, we will make persistent efforts to be more actively involved in the screening of neonatal diseases, to help the city's newborns truly achieve early prevention, early diagnosis, and early treatment, so that more babies can have a healthy future. END. Material Review丨Editor/Supervisor Zhu Yunxia | Health Business Development Department

Top ranking

Links